It's Study Time; This is Your Homework

In my Midday Video for Members today, we are delving more deeply into the resurgent biotechnology and healthcare space. You do not want to miss this video, as we will efficiently scroll through relevant charts and put the puzzle together. 

However, make no mistake that IBB XBI XLV sector ETFs all for bios and healthcare are notably strong and threatening fresh legs higher. 

As evidence, note the IBB, ETF for the large cap biotechs, on the weekly chart, below. 

After a stellar 2012-2015 bull run as a bonafide market leader, bios cooled off for a few years. But, again, after breaking the highlighted triangle higher which we looked at previously, a tighter, smaller bull flag has emerged (arrows).

If IBB can sustain its major breakout from here after a three-year (!) slumber, it is hard to argue with the notion that they can at least contribute significantly to a new bull run, if not be an undisputed leader, once again.